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a b s t r a c t 
Polyfunctional N,O,O,N-type ligands such as the oxalyl dihydrazide (ODH) may induce formation of mono- 
, di-, and polynuclear complexes with natural monoterpene ketones, involving ligand bridging and Oxo- 
bridging. In this context, a novel chiral dihydrazone is designed through hemi-synthesis process by re- 
acting oxalyldihydrazide (ODH) with ( s )-carvone, the major compound of caraway’s seeds essential oil. 
The C = N imine bi-condensation is performed without prior isolation of the natural ( s )-carvone and 
the resulting ( s )-carvone dihydrazone (s-CHD) is structurally characterized by Single-crystal X-ray diffrac- 
tion, 2D-NMR spectroscopy and chiral LCMS analysis to confirm the formation of a single pure enan- 
tiomer. In -vitro cell-based assays were conducted on normal fibroblast (L929) using a presBlue (PB) flu- 
orescence quantification method of cell-viability and by sulforhodamine B calorimetric cytotoxicity as- 
says to determine the anti-proliferative effect on four human tumoral lines (NCI-H460, Hela, HepG2 and 
MCF-7) and normal PLP2. Anti-inflammatory assays were determined through NO production by Maurine 
LPS-stimulated macrophages (RAW 264.7). The ( s )-CHD has no effect on normal cells viability ( > 88%) 
and PLP2 (GI50 = 326 ug/mL), while a moderate ( ∼55%) to significant ( ∼63%) antigrowth potential was 
recorded against HepG2, Hela and MCF-7 tumor cell lines, where RAW 264.7 was feebly sensitive. A 
molecular docking was performed using Autodock vina software on the protein kinase CK2 and Epi- 
dermal Growth factor Kinase proteins EGFK and the dock scores allowed to identify significant bind- 
ing affinities (lower G and Ki values) and potential hydrophilic/hydrophobic interactions with ( s )-CHD 
comparing to the clinical ellipticine as potential ligands. Molecular docking suggests that ( s )-CHD pos- 
sesses high affinity towards the kinase domain receptors CK2 and EGFR, being able to bind to the ATP 
region. 










Plant terpenoids are extremely reactive secondary metabolites 
1] , of large structurally diverse configurations allowing them to be ∗ Corresponding author. 






022-2860/© 2021 Published by Elsevier B.V.  molecular candidate for distinct hemi-synthesis processes [2–4] . 
onocyclic terpenes and their derivatives are valuable molecules 
idely employed as pharmaceutical probes [1] , where several sci- 
ntific investigations pointed their structural importance to in- 
rease chemical properties and bioactivities of novel molecular 
caffolds [5] . The chiral ( S )-( ̶)-carvone (p-mentha-6,8–dien-2-one) 
s a monoterpene ketone naturally occurring in several plant es- 
ential oils (EOs) and has long been proved of no adverse ketone 






























































































































azards [6] . The dextro ( d ) form of carvone is mainly found in cer-
ain plant EOs, including Carum carvi L. (Apiaceae) and Zanthoxy- 
um alatum DC. (Rutaceae) seeds [7–10] , dill Anethum graveolens 
. (Apiaceae) and fennel Foeniculum vulgare Mill. (Apiaceae) seeds 
11] , which are well documented in folk medicine for their reme- 
ies on gastric disorders [ 12 , 13 ]. Besides, the laevo ( l ) form is the
ain constituent of spearmint EOs [11] . Reports [14] have showed 
hat both enantiomers of carvone may be considered as starting 
aterials for biologically active compounds. Previous studies high- 
ighted several pharmacological effects of carvone and its deriva- 
ives as antimicrobial compound [15] , antifungal [16] , and antitu- 
oral [ 15 , 17 , 18 ]. Different conventional methods, such as hydro-
istillation [19] , soxhlet [20] and supercritical fluid extraction [21] , 
re used to extract EOs from C. carvi seeds, where reports usu- 
lly highlighted large amounts of carvone (50–60%) and limonene 
30–40%) in the volatile fraction [ 21 , 22 ]. Post-synthetic modifica- 
ion of ( s )-carvone present in raw plant materials, by mean of its 
etone function, may exhibit interesting biologically active com- 
ounds associated with a chiral interaction that plays a crucial role 
n the elaboration of synthetic or hemi-synthetic anticancer drugs 
 23 , 24 ]. 
Distinguishably, recent scientific reports highlighted the possi- 
ility to convert aldehydes and ketones to hydrazone derivatives 
pon reaction with hydrazine [ 25 , 26 ]. Since hydrazines are more 
ucleophilic than simple amines due to the presence of the ad- 
acent nitrogen, their condensation with carbonyl affords hydra- 
ones in high yields, which are generally formed as a mixture of 
eometric isomers. Hemi-synthetic hydrazones issued from natu- 
al ketones and aldehydes can be further converted to their cor- 
esponding alkane via the Wolff-Kishner Reduction method [27] . 
esides, the di-Schiff bases are polyfunctional N,O,O,N-type lig- 
nds which may form mono-, di-, and polynuclear complexes 
ith monoterpene ketones [ 26 , 28 ] involving ligand bridging and 
xobridging [29] . Thus, the possible C = N imine condensation 
rovided by hemi-synthesis processes may eventually allow ac- 
ess to more potent molecules that may exhibit a promising in 
ivo pharmacokinetic profile and other desirable biological prop- 
rties. Additionally, the ( s )-carvone was commonly used in hemi- 
ynthesis of a wide range of interesting molecules, particularly 
ydrazone derivatives with several interesting biological proper- 
ies that are considered as important complexes for various phar- 
aceutical applications [ 30 , 31 ]. From a biological activity point 
f view, these novel structures may bind to several kinase in- 
ibitors such as CK2 and EGFK offering powerful clinical activ- 
ty with new insights on drug design. Previously, Prudent et al. 
32] discussed the possibility of human protein kinase (CK2) inhi- 
ition by ellipticine as a novel mechanism involved in the tumoral 
rowth inhibition. The authors reported that Cdk2-dependent 
53 phosphorylation is selectively inhibited by ellipticine and 9- 
ydroxyellipticine. The ellipticine derivatives have also inhibitory 
ctivity on the c-Kit, which is supposed to be an antiprolifirative 
gent. 
Due to the outstanding chemical proprieties of the ( S )-carvone 
nd its potential reactivity, the current study reports an in -situ 
mine condensation of C. carvi seeds EOs with oxalyl dihydrazide 
OHD) to obtain a new chiral ( s )-carvone dihydrazone (s-CHD) 
tructure via an hemi-synthetic approach. The resulting com- 
ounds was fully characterized by 2D-NMR, single crystal X-ray 
nd chiral-LCMS. The novel s-CHD molecule was subjected to sev- 
ral bioassays that were screened in -vitro to determine its differ- 
ntial cytotoxicity proprieties in normal and tumor cell lines, as 
ell as, its anti-inflammatory priorities through a down-regulation 
f NO production on LPS-simulated Maurine macrophages. Further- 
ore, the structure-activity-relationship (SAR) of a binary com- 
lex of protein kinase CK2 and ep interaction with our hemi- 
ynthesized s-CHD was studied using molecular docking. 2 . Results and discussion 
.1. Effect of extraction techniques on the chemical composition of 
he volatile oil 
We have first studied several extraction techniques of C. carvi 
eeds EOs and in order to optimize the extraction yield, Clevenger 
ydro-distillation (HD), soxhlet extraction (SE) and supercritical 
uid extraction (SFE) were performed following the parameters 
et in Table 1 . The extractions procedures were set based on the 
hysicochemical proprieties of the targeted compounds and on the 
perating conditions of the extraction system. The influence of 
ach extraction parameter was compared in terms of the visual 
spect of the recovered oil and the extraction yields alongside to 
he major compounds’ amount, particularly the ( S )-carvone and 
imonene content ( Table 1 ). The global yield was measured in trip- 
icate then defined as a ratio (%) of extracted oil mass (g) per plant 
ry seeds (g). Concomitantly, the chemical composition of the ex- 
racts was compared using GCMS analysis ( See Supporting Infor- 
ation ). 
Initially, the visual appearance of the volatile fraction obtained 
rom the three extraction processes was significantly distinct. The 
olor of the oil obtained by conventional HD method was pale yel- 
ow, mostly approximating light-yellow liquid with a specific in- 
ense odor. However, the SE method provided an oil with a specific 
reenish-brown color, which was close to olive green color. The ex- 
racts recovered by the SFE technique had a brownish yellow color. 
he oil obtained from those latter techniques was semi-solid un- 
er ambient conditions (22 °C and 0.1 MPa) due to the presence of 
ther high molecular weight compounds, which were found to be 
resent in large amounts easily extractable with non-polar solvents 
Hexane, supercritical CO 2 ). While, the yield of extractable mate- 
ial obtained by the HD technique was significantly higher than the 
ther two processes 3.85 ± 0.7%, followed by the SE and SFE ex- 
raction giving respectively 2.92 ± 0.5% and 1.37 ± 0.5%, when us- 
ng the whole plant material (integral seeds) and the ground mate- 
ial. Such differences in yield are probably related to the extraction 
arameters as previously highlighted by Assami et al., where the 
ame extraction procedures have been undertaken by different pa- 
ameters to extract the volatile fraction of T. articulata [33] . Chro- 
atographic profiling has shown that the oil was characterized by 
 total of 58 compounds identified in HD extracts, 72 compounds 
n SFE extracts and 78 compounds in SE ( See Supporting Informa- 
ion ), which accounted for 93.71%, 98.62% and 98.5% of the total 
il composition, respectively. 
Herein, the study focuses on the major components identified 
y the above applied methods and more restricted to the amounts 
f ( S )-carvone and ( R )-limonene. The whole composition of the ob- 
ained EOs was profiled by a high presence of monoterpenoid ke- 
ones and cyclic monoterpenes. The major components identified 
n HD extracts were ( S )-carvone (59.53%) and (39.14%) of limonene, 
eing also highly present in SFE extracts at 9.39 to 31.32% for 
he ( s )-carvone and 2.65 to 29.61% for limonene, for the inte- 
ral and grinded seeds, respectively. Exceptionally, sabinene repre- 
ented 34.46% in the oil obtained from SFE of the integrated seeds 
hile β-Myrcene was considerably present in the oil obtained 
y SE and SFE. Additionally, for SE method, the ( s )-carvone was 
resent at 33%, followed by the limonene at 23% and p -cymene 
5.1%. We noticed large differences concerning the nature and the 
xtracted amounts of components according to the selected ex- 
raction process, which is found selective to certain compounds 
ccording to their physico-chemical proprieties such as solubility 
nd diffusivity [34] . The same indications was discussed previously 
35] in relation to the extraction procedure, that highlighted a vari- 
tion in the separated amounts of molecules. Noticeably, when op- 
rating SFE, a change of the extraction temperature in the extractor 
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Table 1 
The extraction conditions, total yield, and major compounds amounts of C. carvi volatile fraction. 
Procedure Hydrodistillation Soxhlet Extraction 
Supercritical Fluid 
All Seeds Grinded seeds 
Solvent Water Hexane CO 2 CO 2 
Temperature ( °C) 100 ± 0.5 70 ± 5 35 ± 1 35 ± 1 
Pression (Bar) – – 125 125 
Flow (ml/min) – – 4 4 
Oil aspect pale yellow greenish-brown brownish-yellow brownish-yellow 
Yield (%) 3.85 ± 0.7 2.92 ± 0.5 1.37 ± 0.5 1.37 ± 0.5 
( S )-carvone (%) 59,53 32,99 38,62 40,09 
( R )-limonene (%) 39,134 23,03 2,65 29,61 







































as considerable effect on the chemical composition of the extracts 
nd the temperature of 40 °C seems to be an optimal condition. 
uthors supports the use of innovative processes such as SFE over 
D to target selective extraction toward certain types of molecules 
n shorter time and at lower temperature as main advantages [36] . 
herefore, previous reports [37] reveled that SFE appears to be the 
ptimum process for obtaining volatile oil of high quality with a 
ood yield. 
.2. ( s )-carvone dihydrazone (s-CHD) synthesis and chemical 
haracterization 
The hemi-synthesis of ( S )-CHD from natural starting material, 
as been achieved by a simple imine bi-condensation reaction of 
 s )-carvone as the major component of the caraway seeds EOs with 
xalyl dihydrazide without any prior purification or isolation from 
he oil matrix. The reactional mechanism is described in Scheme 1 
nd the final product ( S )-CHD is formed with high purity at 82.5%
ield. The existence of several different potential H-bond donor/H- 
ond acceptor groups in the ODH molecule, alongside to the pos- 
ible adopted orientations of the N − H bonds of the amine NH 2 
3 roups with respect to the molecule median plan, leads to several 
ossible geometric conformations and H-bonding arrangements fa- 
orable to connect to monoterpenic ketones through C = N cross- 
oupling. Moreover, ODH is a polymorph which may exist in a 
umber of different energetically accessible conformations with re- 
pect to the orientations of the terminal NH 2 groups [ 26 , 29 ]. 
The rotation of the amine NH 2 group around the NH –NH 2 bond 
s associated with a relatively low energy barrier, and thus a range 
f different conformations of the NH –NH 2 end groups should be 
ccessible for the ( s )-carvone. To the authors knowledge, the fi- 
al compound ( S )-CHD was not reported in the literature and pos- 
esses an asymmetric structure since the reaction was carried out 
ver the ( s )-carvone carbonyl group, ultimately maintaining the 
onfiguration of the asymmetric center of ( s )-carvone. Accordingly, 
he structural elucidation of the synthetized compound was carried 
ut by mass spectrometry and elemental analysis. Basically, the 
ositive-ion API-ES spectrum showed only one peak at m/z 383.2 
100%) ( See Supporting Information ), thus, the molecular-ion peak 
s compatible with the molecular formula C 22 H 30 N 4 O 2 ( M + H ),
hich was further confirmed by elemental analysis C: 66.47%; H: 
.62; N: 15.67%. 
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Fig. 1. (HMBC 1H/13C 2D NMR correlations of ( s )-CHD. 
Fig. 2. (a) Achiral HPLC-UV analysis of ( s )-CHD, (b) detection of pure enantiomer of ( s )-CHD from Chiral HPLC analysis, (c) Carawy EOs separation of the mixture of R- 






























































NMR spectra of caraway seeds EOs confirmed the presence of a 
ixture of carvone and limonene as major compounds by compar- 
son to their standard 1 H NMR spectra ( See Supporting Informa- 
ion ). Interestingly, 1 H NMR spectrum of ( S )-CHD displayed new 
ignals appearing at δ = 10.86–11.14 ppm, being assigned to the 
unctional amine group from ODH, confirming therefore the for- 
ation of the hydrazone ( S )-CHD. Further information can be ob- 
ained from HMBC 1H/ 13 C 2D NMR spectrum, where NH entertains 
orrelation with the carbonyl function; 2-CH 3 shows both corre- 
ations with the imine C = N carbon and C = C intracyclic dou- 
le bond. Other important HMBC connectivities are illustrated in 
ig. 1 . Additionally, duplication of some proton signals, such as 
hose of the amine function and methyl groups is a sign of hav- 
ng asymmetrical conformations present in solution. 
Accordingly, the synthesized molecule ( S )-CHD was analyzed 
y liquid chromatography using an HPLC C18 reversed-phase (UV- 
etection at wavelength 254 nm, eluent and sample solvent: ace- 
onitrile/water 70:30 v/v, injected volume of 20 μl), where the LC 
hromatogram ( Fig. 2 ) showed the presence of one sharp peak, 
ndicating a high purity of the product without any possible in- 
erferences being formed within the matrix. Additionally, a simi- 
ar LC profile of ( S )-CHD was obtained from chiral HPLC separa- 
ion, which proved the existence of pure enantiomer appearing as 
 unique peak at a distinct retention time (14.54 min) comparing 
o those recorded for the mixture of R-limonene and S-carvone (at 
.39 min and 7.25 min, respectively) from the caraway EOs Chi- 
al HPLC analysis ( Fig. 2 ). This finding confirms the formation of 
 single chiral core without any impurities originating from traces 
ssential oil waste. 
The X-ray diffraction studies reveal that the ( s )-CHD is com- 
rised of enantiomorphic triclinic P1 space group with the asym- 
etric unit having only one molecule exhibiting ( S )-configuration 
 Fig. 3 ). Although, the crystal structure displays a pseudo center of 
ymmetry element with 89% fit, tests with PLATON/ADDSYM [38] , o
4 evealed the existence of pseudo-translations, but no obvious need 
or a space group change. LEPAGE cell symmetry tools also indi- 
ated no alternative metrical symmetry found. All non-hydrogen 
toms were refined anisotropically and the hydrogen atoms were 
nserted in idealized positions and allowed to refine riding on 
he parent carbon atom. In addition, using the natural source ( s )- 
arvone as a starting chiral reagent implying that the product ob- 
ained was crystallized in chiral and asymmetric space group. The 
symmetric unit presents hydrogen bonds interactions, which are 
escribed in Fig. 3 [39] . Moreover, the comparison of the experi- 
ental powder diffraction pattern with the theoretically predicted 
sing data from single crystal diffraction were proved that the re- 
ulting compound represent the bulk of the product obtained, thus 
ssuring the homogeneity of the synthesized compound in 95% 
ield ( See Supporting Information ). 
.3. Bioactivities evaluation 
Cell-based viability assays enables monitoring cytotoxic events 
n populations of cells exposed to a new synthesized molecule 
40] . First, the normal L292 fibroblasts cells viability was mon- 
tored through the evaluation of viable cell levels exposed to a 
oncentrations range of ( s )-CHD in aqueous solutions as summa- 
ized in Table 2 . The ( s )-CHD has been shown to have slight ef-
ect on normal cell growth that was not a dose-dependent manner. 
he representative dose-response survival values indicated that at 
he lowest molar concentration (0.7 μM), 90% of viability was 
ecorded, while at the highest concentration (100 μM) a high vi- 
bility rate (82%) was either obtained. Tehrani et al., reported the 
ame behavior of the hydrazine and arylhydrazone derivatives on 
broblast L929 cells that remain viable even at higher concentra- 
ions [41] . These results showed the suitability to investigate the 
ytotoxicity of the synthesized ( s )-CHD on tumoral lines. On the 
ther hand, the growth inhibitory effect of the ( s )-CHD on four 
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Fig. 3. Schematic representation of ( S )-Cravone hydrazone, using 30% probability level ellipsoids. MERCURY packing diagram showing hydrogen bonds (represented by dashed 


















uman tumor cell lines (NCI-H460, Hela, HepG2 and MCF-7) and 
ormal PLP2 was evaluated in -vitro using Sulforhodamine B col- 
rimetric assay and the results were expressed in GI50 as summa- 
ized in Table 2 . 
Ellipticine, a clinically used antitumor agent was also evaluated 
s a positive control. The tumoral cells response towards ( s )-CHD 
as from a moderate to significative inhibition of cell prolifera- 
ion being specially active against Hela, MCF-7 and HepG2 that ex- 
ibited equipotent activity as evidenced by a lower GI 50 values of 5 50.6 ± 7.4 μg/mL, 176.9 ± 7.6 μg/mL and 178.9 ± 6.4 μg/mL re- 
pectively. In contrast, the ellipticine was far more effective record- 
ng a high antigrowth potency depicted through lower GI 50 value 
 < 2 μg/mL) against all cells line. Interestingly, the normal PLP2 
ells growth was poorly affected by ( s )-CHD with higher GI 50 of 
25.9 ± 11.2 μg/mL. Thus, it was noticed through the obtained re- 
ults that the ( s )-CHD exhibited a selective potency against Hela, 
CF-7 and HepG2 cells compared to the conventional chemother- 
peutic drug (ellipticine) that affected the growth of all the cell 
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Table 2 
Cell viability, cytotoxicity against tumoral lines and anti-inflammatory assays of (S)-carvone hydrazone. 
Cell viability 
Concentration (μM) 0 0.7 1.5 3 6 12 25 50 100 
Viability ∗ (%) 100 90 ± 4.1 94 ± 2.1 93 ± 3.2 92 ± 3.2 93 ± 1.5 91 ± 4.1 88 ± 7.2 82 ± 1.6 
Cytotoxicity 
Growth inhibition values (GI 50 , μg/mL) Cell lines (s)-CHD Ellipticine 
NCI-H460 188.9 ± 7.4 1.03 ± 0.09 
Hela 150.6 ± 7.4 1.91 ± 0.06 
HepG2 178.9 ± 6.4 1.1 ± 0.2 
MCF-7 176.9 ± 7.6 0.91 ± 0.04 
PLP2 325.9 ± 11.2 3.2 ± 0.7 
Anti-inflammatory 
Nitric oxide NO. production (IC 50 , μg/mL) RAW 264.7 (s)-CHD Dexamethasone 
222.3 ± 4.1 16 ± 1 
GI50 values (mean ± SD) correspond to the sample concentration achieving 50% of growth inhibition in human tumor cell lines or in liver primary culture PLP2. NCI-H460: 
Non-small cell lung carcinoma, HeLa: Cervical carcinoma, HepG2: hepatocellular carcinoma, MCF-7: Breast carcinoma. IC50 values (mean ± SD) correspond to the sample 
concentration achieving 50% of the inhibition of NO-production. RAW264,7: Murine macrophages. Viability ∗ (mean ± SD), values represent the percentage of cell viability of 



















































































ines even the normal PLP2 cells. This behavior may be contrasted 
ith the structural configuration of the ( s )-CHD that may inter- 
ct specifically with certain protein receptors involved in tumoral 
rowth processes. Accordingly, the observed cytotoxic effects may 
e partially attributed to the NH proton and the carbonyl group 
eactivity that enable a significant antiproliferative activity through 
omplexation with cell’s DNA or proteins such protein kinase CK2 
nd epidermal growth factor kinase, that are involved in tumoral 
ell growth, cell differentiation, apoptosis and oncogenic transfor- 
ation [ 42 , 43 ]. Previously, Golla et al., [44] reported that a suc-
inohydrazone derivative, where the structure is close to the ( s )- 
HD, conferred higher cytotoxicity against human breast adeno- 
arcinoma cells (MDA-MB-231) and was non effective against hu- 
an cervical carcinoma (HeLa) and human lung carcinoma (A549) 
ells. Furthermore, the anti-inflammatory results were recorded on 
he NO levels for the LPS-stimulated RAW 264.7. The LPS stimu- 
ation polarizes macrophages toward the M1 phenotype, which is 
haracterized by the production of high levels of pro-inflammatory 
ytokines, inducing production of nitric oxide (NO) [45] . The re- 
ponse of the cells exposed to the ( s )-CHD were less sensitive 
high IC 50 intermediate response), with a persistent formation of 
O during the inflammatory process. The ( s )-CHD could partially 
own regulate NO production comparatively to the dexamethasone 
ith higher anti-inflammatory potential used as positive control. 
.4. Molecular docking 
Since CK2 and EGFR expression are involved in tumoral cells 
rowth and proliferation [ 42 , 43 ], their possible inhibition is seen 
s a promising approach for innovative therapeutic strategies in 
ancer treatment. In order to test whether the designed molecule 
 s )-CHD could inhibit the ligand binding-induced receptor, a virtual 
olecular docking was performed on research hypothesis consider- 
ng the recorded cytotoxic potential using Autodock vina software. 
he docking scores of the binding affinity ( G), root mean square 
eviation (RMSD), inhibition constant (Ki) and the intermolecu- 
ar interactions of ( s )-CHD and the standard ellipticine with the 
TP binding pocket of the CK2 and EGFRK receptors are presented 
n Table 3 . For ellipticine, the molecular docking was performed 
n the basis of its binding energy and overlay methods, which 
hould confirm the possible similarities in binding patterns that 
ay occur with the ( s )-CHD. Autodock vina scores makes clear that 
he ( s )-CHD has a significant G values of −9.4 (Ki = 0.127 μm)6 nd −8.3 Kcal/Mol (ki = 0.812 μm) with CK2 and EGFK binding 
ites respectively. The designed molecule was found to bind on the 
ame binding site with the ellipticine that exhibited close inter- 
ction scores on the same receptors (CK2, G = −8.3 Kcal/Mol, 
i = 0.02 μm; EGFK, G = −8.5 Kcal/Mol, ki = 0.579 μm). This in-
eraction affinity is due to the existence of potential H-bond donor 
nd H-bond acceptor groups as well as the hydrophobic interac- 
ions with the docked molecules. For the ( s )-CHD, the N − H bonds 
f the secondary amine and the oxygen atom of the carbonyl group 
 = O may adopt different orientations [26] . A possible geomet- 
ic permutation for hydrogen-bonding arrangements are formed in 
wo site point interactions (H-bonds) of less than 3 Å length with 
he binding site residue of ASN118:HD22 (2.6 Å) and HIS160:HE2 
2.31 Å) residue for CK2 and three strong conventional H-bond 
ith ASP831:OD residue (2.13 to 2.97 Å) for EGFK ( Fig. 4 ). The ob-
erved hydrogen bonds in the ( S )-CHD demonstrate the importance 
f the amine moiety and C = O groups in this intermolecular in- 
eraction of receptor’s pocket. It was also noticed that hydrophobic 
nteractions were formed between the ( s )-CHD and CK2 involving 
ainly the residues VAL53, VAL66, MET163, ILE 174 and HIS160 
ue to an electron-donating groups on the ( S )-CHD phenyl rings 
hat increase the electron density. For instance, in the case of CK2, 
he ( S )-CHD is further stabilized by the external side of the ATP 
ocket by the mean of π-interaction between its phenyl ring and 
istidine at position 160 ( Fig. 4 ). Besides, the perillalkyl groups and 
he phenyl rings of the ( S )-CHD were positioned in a way that can
t deep into the hydrophobic pocket of CK2 and EGFR. The intro- 
uction of electron-donating groups ( π-electron donating) on the 
henyl ring increases the electron density, thereby enhancing the 
nteraction with the chosen receptors. In the case of the EGFR, ( S )- 
HD adopted interesting electrostatic interaction (salt bridge) be- 
ween positive NH groups and Negative ASP831:OD1 (2.39 Å) and 
SP831:OD1:B (2.97 Å). Similarly, an interesting pose was set on 
he phenyl ring and extended towards the entrance of the receptor 
inding site and formed π-alky/ π-orbitals interaction with Phe699 
4.94 Å). 
Ellipticine on the other hand, has shown similar binding con- 
ormation with negative higher values of G, the carbazole moi- 
ty forming parallel displaced T-shape and π-stacking interactions 
ith HIS160 and PHE113 in the case of CK2 and formed π- σ
nd π-sulfur interaction, respectively, with VAL702:CG1,2,3 and 
ET742 residues in the EGFK ATP pocket. In the predicted bind- 





















































The docking scores of the binding affinity ( G), root mean square deviation (RMSD), inhibition constant (Ki) and the intermolecular interactions of (s)-CHD and the standard ellipticine with the ATP binding pocket of the CK2 






(Kcal/Mol) RMSD ( ̊A) 
Inhibition 
constant, ki (μm) Amino acids involved and binding distance 
H-binding interaction 






CK2 (3owj) (s)-carvone 
hydrazone 
((s)-CHD) 
-9,4 6.751 0,127 4 H-bonds Distance( ̊A) Alkyl/alkyl Distance( ̊A) / GLY 46, 
ASN118:HD22 
/(s)-CHD_O 
2,6 VAL53 /(s)-CHD 3,81 ASP120 
ASN118:HD22 
/(s)-CHD_N 
2,6 (s)-CHD_CH/ VAL66 4,10 
HIS160:HE2 
/(s)-CHD_O 
2,39 (s)-CHD_CH/ MET163 4,66 
HIS160:HE2 
/(s)-CHD_N 
2,31 (s)-CHD_CH/ ILE174 4,58 
π-Alkyl/ π-Orbitals 
HIS160/ (s)-CHD 5,24 
Ellipticine 
(ELP) 




/ LEU45 _O 
3,6 VAL53 / ELP 3,53 HIS160 /(s)- 
CHD3,97 
Å 
ILE174 / ELP 3,87 
ILE174 / ELP 3,83 
ILE174 / ELP 3,63 
π-stacking 
PHE113 /(s)-CHD 4,26 
ELP/ PHE113 5,97 
HIS160 /ELP 4,94 
ELP/ VAL66 5,45 
π-alkyl 
ELP/ ILE95 4,85 
ELP/ VAL53 5,00 
ELP/ VAL66 4,67 
ELP / MET163 5,41 
ELP/ ILE174 5,47 
ELP/ VAL53 3,97 




























































RMSD ( ̊A) Inhibition 
constant, ki (μm) 
Amino acids involved and binding distance 
H-binding interaction 
H-Donor/H-Acceptor 






EGFK (1m17) (s)-carvone 
hydrazone 
((s)-CHD) 














2,97 ALA719 /(s)-CHD 4,79 (s)-CHD_NH 
/ ASP831 2,39 Å 
(s)-CHD_NH 
/ ASP831: OD2 
2,13 LYS721 /(s)-CHD 5,09 (s)-CHD_NH 
/ ASP831 2,97 Å 
LEU820 /(s)-CHD 5,34 
(s)-CHD_CH/ VAL702 5,41 














2,87 VAL702 /ELP 3,89 Å 
ELP_NH/ 
ASP831 
2,75 VAL702 /ELP 3,85 Å 
VAL702 /ELP 3,96 Å 
π-alkyl 
ELP/ LYS721 4,96 Å 
ELP/ VAL702 4,94 Å 
ELP/ LYS721 5,06 Å 
ELP/ LEU820 5,47 Å 
s ELP/ LEU694 5,16 Å 
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y interaction of the NH group of the carbazole moiety with oxy- 
en atom of ASP831:OD1 (2.87 Å) and ASP831:OD1:B (2.75 Å) with 
 binding energy of −8.5 Kcal/mol. It should be considered that 
 S )-CHD contains two connected nitrogen atoms, two connected 
arbonyl groups and C –N double bonds that are conjugated with 
n electron pair. This structural configuration is mainly respon- 
ible of physico-chemical proprieties of the synthesized ( S )-CHD. 
oth nitrogen atoms of the hydrazine group are nucleophilic and 
ay exhibit considerable reactivity and different electronic inter- 
ctions with the amino acids involved in the active pocket of the 
ocked proteins, hence, ( S )-CHD can be considered as an ATP- 9 ompetitive CK2/EGFK inhibitor. For the EGFK, this inhibition is 
ossible when the ligand poses are included in the forty amino 
cids from the carboxyl-terminal tail, that are distinguished in pos- 
essing constitutive kinase activity of ATP phosphorylation event 
ithin their kinase domains [ 46 , 47 ]. Herein, the ( S )-CHD docking
ites are found in close contact with the kinase domain where the 
nteracted amino acids are involved between the EGFRK domain 
nd carboxyl-terminal substrate. 
The majority of subsequent biological studies have discussed 
he DNA topoisomerase and telomerase enzymes as particular tar- 
ets for ellipticine being known for its topoisomerase inhibition 













































































































athway. However, ellipticine has largely been reported to have as- 
orted molecular targets and its action was not only limited to DNA 
opoisomerase, it was even proved to inhibit other proteins in- 
olved in the tumor growth process, such as CK2 [32] . Accordingly, 
 comparative docking study of s-CHD and ellipticine was estab- 
ished on CK2 and EGFR to determine whether the two molecules 
ay exhibit affinity for the same receptor site and to identify the 
ature of interactions. Current findings based on that theory were 
ery promoting, since a close binding scores and similar linking 
ites were virtually found in the ATP binding pockets. The docking 
esults, afforded valuable information for another possible inhibitor 
ction of ellipticine, which is the EGFR kinases. 
. Conclusions 
The present study relates to the hemi-synthesis of ( S )-carvone 
ydrazone ( S )-CHD as a novel symmetrical chiral ligand obtained 
rom caraway essential oil which majorly contains the naturally 
ccurring ( S )-carvone. The reaction is performed via an imine bi- 
ondensation of oxalyldihydrazide (ODH) on the carbonyl group 
f ( S )-carvone without any prior purification or isolation of this 
tarting keto-terpene from its oil matrix. ( S )-CHD was fully char- 
cterized by 2D-NMR spectroscopy and chiral LCMS analysis evi- 
encing therefore, the formation of a single pure enantiomer. The 
rystal structure was further confirmed by using Single-crystal X- 
ay diffraction Biologically, ( S )-CHD does not affect normal cells 
iability but has an important cytotoxic potential against HepG2, 
ela and MCF-7 tumor cell lines. The ( S )-CHD docking studies have 
roved high affinity towards the kinase domain of the receptors 
K2 and EGFRK, being able to bind to their kinase ATP region and 
nduce their inhibition. 
. Materials and methods 
.1. Chemicals and apparatus 
All the solvent and products were employed as received 
ithout further purification and were purchased from Sigma- 
ldrich. Cryst al structure refinement is performed using Single- 
rystal X-ray diffraction (Benchtop X-Ray Diffractometer RIGAKU 
odel MiniFlex II; transmission mode; Cu KR1 radiation (Ge- 
onochromated)). Clevenger apparatus, Supercritical fluid extrac- 
or and Soxhlet are used for plan essential oil extraction. NMR 
pectra are recorded on a 400 MHz Brüker (Avance III NMR. Spec- 
rometer). LC-MS analysis was carried out in Agilent 1200 se- 
ies/Agilent 6130B Single Quadrupole. Additionally, Chiral chro- 
atographic separation was performed on LC Waters 600 multi- 
olvents delivery system equipped to UV–vis detector. 
.2. Plant material 
Dry seeds of C. carvi L. (around 5 Kg) were purchased from 
ocal selling point in Algiers -Algeria- during June 2019. Botani- 
al authentication of the plant seeds was made by taxonomist at 
he National School of Agronomy-Algeria-. The collected biomass 
as ground to a fine powder ( ∼2 mm mesh size) using an electric 
sing Bel-Art Micro-Mill Grinder with Timer; Stainless Steel Blade 
nd Grinding Chamber; 115VAC, 60 Hz (H37252–0 0 0 0) before ex- 
raction. After grinding, the samples were weighed then stored in 
ealed glass jars and kept at 4 °C ( ±0.5 °C). 
.3. Essential oils extraction 
Caraway volatile compounds were extracted using three extrac- 
ion methods. Hydrodistillation, Soxhlet (or Clevenger) extraction 
nd Supercritical CO extraction. 2 
10 .3.1. Hydrodistillation (HD) 
The HD method was established as previously reported [33] . 
here an amount of 100 g of crushed plant samples was mixed 
ith 500 ml distillated water in 1 L flask and a closed Clevenger 
pparatus was mounted with condenser unit connected to WISE- 
IRCU thermostat connected to Fisher Scientific Polystat 36 with 
 cooling capacity over the entire temperature to −30 °C. EOs ex- 
raction was processed in closed cycles at atmospheric pressure for 
 h. After extraction, the volatile distillate was collected over an- 
ydrous sodium sulfate and refrigerated at 4 °C prior to analysis. 
.3.2. Soxhlet extraction (SE) 
A conventional solid-liquid extraction was performed by Soxh- 
et extractor (- 40 mm ID, with 250-mL round bottom flask) us- 
ng a constant ration of 1:20 (m/v) matrix/solvent according to the 
rocedure described in the literature [22] . An amount (25 g) of 
rinded seed materials was placed in the thimble-holder and the 
xtraction was performed with 200 mL of n-hexane (bp 68.5 °C) 
uring many cycles for an interval time of 6 h. After cooling, the 
rapped oil in the solvent was separated using rotary evaporator 
Büchi R-210, Flawil, Switzerland) under vacuum at temperature of 
5 °C. 
.3.3. Supercritical CO 2 extraction (SCF) 
SCF extraction was carried out using a laboratory-scale sys- 
em (Speed-SFE) previously optimized according to the methodol- 
gy developed by [21] . The extraction was carried out in a cylin- 
rical extractor vessel (500 mL, length 35 cm and internal diam- 
ter 5 cm) which was loaded a steel mesh filters on both end 
ides. The supercritical CO 2 was passed continuously in current 
ow (4 ml/min) for 2 h through the stationary bearing seeds (ap- 
roximately 75 g of grinded seeds) at a temperature and pressure 
bove the critical values. Experimentally, to ensure a better equi- 
ibrium distribution of volatile oil component between the seeds 
nd the solvent and a good mass transfer rate of the oil from the 
eeds to the solvent, the temperature was set at 35 °C and the 
ressure at 125 Bar. The CO2 can then be depressurized to atmo- 
pheric pressure and the extracts obtained were collected into a 
lean vial. The residual solvent was evaporated under vacuum to 
alculate the extraction yield then stored at 4 °C prior to analysis. 
.4. GC–MS analysis of the EOS 
A GC–MS instrument (Konic, HRGC 40 0 0B Gas Chromatograph 
quipped with auto-sampler and capillary injector). A volume of 
.0 μl of Eos was injected into the GC equipped with an HB5MS 
olumn (30 m x 0,25 mmi.d, film thickness 0,25 μm; Hewlett- 
ackard, 5% Phenyl 95% dimethylpolysiloxane stationary phase). 
he injector was set at 280 o C and He (99,995% purity) was used 
s carrier gas with a linear velocity of 1 ml/min. GC–MS setting 
arameters were fixed using the following conditions: split flow 
0 ml/min; Initial oven temperature was 60 ᵒ C and holding time 
as 1 min: then progressed from 60 to 300 ᵒ C at 10 ᵒ C/min; oven
un time was 26 min; the ionization mode used with electronic 
mpact at 70 eV. The compounds of the EOs were identified after 
njecting a mixture of alkanes (C 6 - C 24 ) under the same operating 
onditions by comparing their kovats index (KI) with those cited in 
he literature as well as with those of standards injected under the 
ame conditions. Confirmation of the eluted compounds was based 
n the mass spectral of the fragmentation patterns using Wiley-8 
nd NIST-14 Database mass spectrometry libraries. 
.5. General procedure for the ( s )-carvone hydrazone synthesis 
Amount of ODH (0.142 g, 1.2 mmol) was added to a mixture 
olution of ethanol and water (80/20) and let for 5 min under con- 



















































































































inuous stirring. The caraway seed essential oil (1 mmol of ( S )- 
arvone with a molar excess calculated on the basis of 60% of 
ass, approximately 0.26 ml or 0.251 g of the crude oil) is added 
nd the resulting mixture was brought to react at 80 °C under re- 
ux for 6 h. The mixture was then cooled to 20 °C and filtered
nder vacuum. The precipitate was washed with pure ethanol and 
ollowed with ethylic ether to eliminate the remaining impurities 
f the starting crude material. The white crystal product is then 
ir-dried, yielding the desired s-CHD compound (0.207 g, 82.5%). 
.6. Chemical characterization 
.6.1. Chiral HPLC and LCMS analysis 
Chromatographic characterization of the synthesized compound 
as performed by liquid chromatography-HPLC following the 
ethodology described by [49] . The compound was prepared at a 
atio of acetonitrile/water (70:30 v/v, HPLC-grade) and further fil- 
ered through a Whatman 0.45 μM syringe filter. The equipment 
as a Waters 600 HPLC multi-solvent delivery system with a 225 
L pump head volume at 45 mL/min flow rate and auto-sampler 
Marshall Scientific, Milford, USA) equipped with UV–Vis and re- 
ractive index detector (Marshall Scientific, Milford, USA). The anal- 
sis was achieved in isocratic elution mode on a C18 reserve 
hase column (30 mm × 4.6 mm × 5 μm, Discovery columns, 
erck, Germany) at a flow rate of 1.0 ml/min and wavelength at 
54 nm an injection of 20 μl. additionally, the high performance 
iquid chromatography coupled to a mass spectrometer was car- 
ied out in Agilent 1200 Series with binary pump and MS Agi- 
ent 6130 (Agilent Technologies, USA) single quadrupole with an 
lectrospray ionization (ESI) source were recorded in negative and 
ositive modes. The identifications were performed in the same 
revious conditions at a flow rate of 0.4 ml/min. Furthermore, 
he enantiomer separation of essential oil and sample analysis 
ere determined using chiral column type CHIRALPAK® IB (Chiral 
echnologies Europe, Illkirch, France) stationary phase cellulose- 
ris(3,5-dimethylphenylcarbamate) immobilized on 5 μm silica-gel, 
50 mm × 4.6 mm ID). The mobile phase used was hexane/ iso- 
ropanol (isocratic mode, 60:40, ( ʋ/ ʋ)) at a flow rate of 0.5 ml/min
anging in wavelength from 190 nm to 400 nm an injection 
f 5 μl. 
.6.2. NMR spectroscopy analysis 
1 H, 13 C and 2D NMR spectra were recorded at 298 K on Bruker 
V III 400 MHZ Spectrometer using tetramethylsilane (TMS) as 
n internal reference. The synthesized compound was dissolved in 
DCl 3 for the analysis. The chemical shifts were expressed on the 
cale of ppm and were referenced to residual CHCl 3 at δ 7.26 for 
roton and δ 77.0 for carbon. Unequivocal 13 C assignments were 
ade with the aid of 2D gHSQC and gHMBC experiment. Contrary 
o crude oil and limonene were characterized in DMSO–d6 solvent 
nd referenced at δ 2.50 ( δ 3.33 H 2 O) for proton and δ 39.52 for 
arbon. Coupling constants (J) are reported in hertz (Hz). The terms 
, d, m refer to singlet, doublet and multiplet, respectively. 
Compound S-CHD : N’1,N’2-bis((S,Z) −2-methyl-5-(prop–1-en- 
-yl)cyclohex-2-en-1-ylidene)oxalohydrazide, C 22 H 30 N 4 O 2 : (MW: 
82.51 g/mol, white crystals, 82.5 yield, mp = 184–185 °C). 1 H 
MR (DMSO–d 6 , 400 MHz): δ 1.56 – 1.90 (s, 12H, C H 3 ), 2.00 
 2.42 (m, 8H, C H 2 ), 2.79 – 2.90 (m, 1H, C H ), 4.74 – 4.83 (d,
 = 11.7 Hz, 4H, C = C H 2 extracyclic), 6.00 – 6.40 (2H, m, C = C H
ntracyclic), 10.39 and 11.00 (2 s, N H ) ppm. 13 C NMR (DMSO–d 6 ,
00 MHz): 17.73, 18.14, 20.90 and 21.20 ( C H 3 ), 29.60 and 29.86
 C H), 30.26 and 30.37 ( C H 2 ), 110.43 and 110.70 ( C = C H 2 extracyclic),
32.29 ( C = CH 2 extracyclic), 132.54 and 136.21 ( C = C H intracyclic), 
47.85 and 147.95 ( C = CH intracyclic), 157.46 (NH –C = O ), 160.18
NH –N = C ) ppm. MS ESI + C 22 H 30 N 4 O 2 ( M + H ) m/z 383.2 (100%),
xact Mass: 382.24. Elemental Analysis calculated C, 69.08; H, 7.91; 11 , 14.65, found: C: 66.47%; H: 7.62; N: 15.67%. Optical rotation: 
 103.25 °
.6.3. X-Ray powder diffraction (XRDP) measurements 
The samples were carried out on a Benchtop X-Ray Diffractome- 
er RIGAKU model MiniFlex II equipped with copper that was used 
s the source of the X-ray tube in a scanning range of 3–145 ° (2 θ ),
canning speed 0,01–100 °/min (2 θ ) and a minimum step width 
,01 ° (2 θ ). A sufficient amount of synthesized compound was sup- 
lied to cover 2 cm 2 of the sample plate. 
.7. Bioactivity assays 
.7.1. PrestoBlue TM cell viability assay 
Cell viability assay was evaluated on fibroblast cells model 
L929) exposed to a different molar concentration of ( s )-CHD aque- 
us solutions (0.7, to 100 μM) following the methodology of [50] . 
wo independent viability tests were monitored for 24 h and the 
esults were expressed in percentage (%). Living cells quantification 
as determined by PrestoBlue TM (PB) reagent used as cell viability 
ndicator that became highly red-fluorescent dye by the reducing 
nvironment within viable cells. The color change can be detected 
uorometrically (excitation 544-nm and emission 590-nm) using 
n automated microplate fluorometer (SerColab System). 
.7.2. Antiproliferative assay 
Cytotoxicity of the ( s )-CHD was evaluated by antigrowth effect 
n tumoral cells according to the procedure described by [51] . Four 
uman tumor cell lines, NCI-H460 (non-small cell lung cancer), 
ela (cervical carcinoma), HepG2 (hepatocellular carcinoma), MCF- 
 (breast carciroma) were selected for the assays. The cells were 
rown under standard cell culture conditions to be sub-cultured in 
6-well plates at a density of 1.0 × 10 4 cells/well for the analysis. 
he Sulforhodamine B colorimetric assay was used to determine 
he cells growth inhibition exposed to a range of ( s )-CHD concen- 
rations serially diluted in ultrapure water starting from 8 mg/mL. 
ikewise, the hepatotoxicity was conducted using a primary cul- 
ure of non-tumor liver cells (PLP2). Ellipticine was used as pos- 
tive control and the final results were presented in GI50 values 
concentration that inhibited 50% of the cell growth). 
.7.3. Anti-inflammatory activity 
For the anti-inflammatory assay was performed in -vitro using 
 cell-based model of lipopolysaccharide (LPS)-stimulated (RAW 
64.7) murine macrophage-like cell line as previously described 
51] . The assay is able to determine the anti-inflammatory activ- 
ty of the produced molecule at different concentrations (serially 
iluted in ultrapure water starting from 400 μg/mL) basing on 
easurement of NO levels produced by the stimulated RAW 264.7 
ells. The response to a fixed dose of LPS is verified spectropho- 
ometrically (515 nm) with nitrite NO levels measuring using the 
riess reagent system kit and the results were expressed as IC50 
alues, corresponding to the sample concentration giving 50% of 
O production inhibition. Dexamethasone (Thermo Fisher Scien- 
ific Co., Waltham, MA, USA) used as a positive control. 
.8. In silico molecular docking 
A crystalized structure of human protein kinase CK2 (PDB en- 
ry: 3owj) and human Epidermal growth factor protein kinase do- 
ain EGFRK (PDB entry: 1m17) was selected and obtained from 
he Protein Data Bank ( https://www.rcsb.org/structure/3OWJ and 
ttps://www.rcsb.org/structure/1M17 ). The receptor proteins (3owj 
nd 1m17) were first prepared for molecular docking by remov- 
ng present ligand heteroatoms and water molecules using protein 
isualization UCSF chemira 1.14 software (U. of California, USA), 













































































nd by addition of polar hydrogens followed by Kollman charges 
djustment on AutoDock tools 1.5.7 software (ADT, The Scripps 
esearch Institute, La Jolla, CA, USA). The set files of the recep- 
ors was saved as protein.pdbqt. MarvenSketch Software was used 
or chemical drawing and 3D.pdb graphics of the ligand ( s )-CHD 
hat was further prepared for molecular docking simulation by set- 
ing the torsion tree and rotatable, nonrotatable, as well as unro- 
atable bonds present in the ligand through AutoDock tools soft- 
are then the obtained file was saved as ligand.pdbqt. The bind- 
ng site of the receptor proteins is identified by using various pro- 
ein visualization software such as PyMol 2.1 and Biovia DS visu- 
lizer according to the indications previously reported by the lit- 
rature [ 32 , 48 ]. An appropriate grid box was set by running Auto-
rid utility of the AutoDock suite to cover all the macromolecular 
esidues involved in the binding of the ligand as indicated in Ta- 
le S19 in the Supporting Information. The grid dimensions enu- 
erate the x,y,z points of the grid box required to perform the 
olecular docking simulation of the receptors and saved as con- 
g.txt file to be processed by Autodock vina [52] to further set up 
he scoring function and binding sites. The PyMOL software 2.1.0 
Schrödinger Co., New York, NY, USA) was used for docking confor- 
ation analysis while the DS visualizer Software was used for 3D 
ocking figures, calculations of interactions sites and distances and 
o build 2D graphics for visualization/interpretation of the recep- 
or amino acids/ligand interaction. The molecular docking affinity 
f the receptors/ligand is validated basing on the obtained binding 
nergy ( G) that should be ranging from −5 to −15 kcal/mol, on 
he values of RMSD ( ̊A), predicted inhibition constant (Ki) and in- 
eraction types and distances ( ̊A). The G of the small molecules 
ith macromolecular targets is predicted by using the semiempiri- 
al force field. All the results obtained by molecular docking simu- 
ation were evaluated on the basis of hydrophilic and hydrophobic 
nteractions obtained between the binding residues present in the 
ctive ligand binding site of the macromolecule and the ligand. 
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